Cargando…
Poor adhesion of fentanyl transdermal patches may mimic end-of-dosage failure after 48 hours and prompt early patch replacement in hospitalized cancer pain patients
CONTEXT: Renewal of fentanyl transdermal patch (transdermal therapeutic system [TTS]) should occur every 3 days (72 hours) according to manufacturer’s guidelines. Some studies mentioned patients reporting end-of-dose failure, and thus, some authors recommend shortening the interval of application to...
Autores principales: | Arnet, Isabelle, Schacher, Sabrina, Balmer, Eva, Koeberle, Dieter, Hersberger, Kurt E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108613/ https://www.ncbi.nlm.nih.gov/pubmed/27877065 http://dx.doi.org/10.2147/JPR.S116091 |
Ejemplares similares
-
Fungal Endocarditis Secondary to Transdermal Fentanyl Patch
por: Casey, Bradley, et al.
Publicado: (2023) -
Transdermal fentanyl patch in post-operative patients: Is it justified?
por: Nair, Abhijit S
Publicado: (2017) -
Fatal Transdermal Fentanyl Patch Overdose in a Child
por: Hilado, Mark A, et al.
Publicado: (2020) -
Fatal intoxication caused by the application of the multiple transdermals patchs of fentanyl
por: Serghini, Issam, et al.
Publicado: (2015) -
Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl
por: Kuip, Evelien J.M., et al.
Publicado: (2018)